LabMedica

Download Mobile App
Recent News Expo
Medica 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

By LabMedica International staff writers
Posted on 19 Nov 2026

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse patient population and experienced investigators. To strengthen local research infrastructure, a newly announced expansion will introduce clinical trial kit assembly and future laboratory operations closer to research sites and patients.

Labcorp (Burlington, NC, USA) is collaborating with Grupo Fleury (São Paulo, Brazil), one of Brazil’s leading healthcare and diagnostic groups, to expand its clinical trial operations in the country. The partnership combines Labcorp’s global central laboratory expertise with Grupo Fleury’s extensive laboratory infrastructure, scientific capabilities, and established presence in Brazil’s healthcare sector. The collaboration aims to provide clinical trial sponsors with local operational support while maintaining consistent quality standards, scientific expertise, and data integrity across Labcorp’s global laboratory network.


Image
Image

The expansion will begin with local clinical trial kit assembly, scheduled to start in early 2027, followed by laboratory operations expected to launch by the end of 2027. Both operations will follow Labcorp’s established global systems, processes, and quality standards to ensure consistency in supporting multinational clinical trials.

Labcorp’s wholly owned central laboratory network currently spans North America, Europe, Asia, and Africa, with the Brazil collaboration extending its clinical trial support capabilities across five continents. By establishing local operations, the company aims to shorten kit delivery times, reduce dependence on international shipping, and improve operational efficiency for clinical trial sponsors. The additional infrastructure is also expected to strengthen support for global studies by bringing clinical trial services closer to research sites and patients throughout Brazil.

“Brazil continues to strengthen its position in global clinical research, supported by a diverse patient population, strong scientific capabilities and experienced research teams. By combining Grupo Fleury's scientific expertise, operational excellence and deep understanding of the local research environment with Labcorp's global clinical trial capabilities, we can help make clinical trials more efficient, broaden access to research opportunities and support the continued development of Brazil's clinical research ecosystem,” said Edgar Rizzatti, president of Grupo Fleury's Medical, Technical, Hospitals, New Links and Innovation Business Unit.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)

Latest Industry News

CNB 2026 Unites Laboratory Professionals in Cali Around Diagnostic Innovation
18 Nov 2026  |   Industry

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians
18 Nov 2026  |   Industry

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study
18 Nov 2026  |   Industry